Release Date: January 30, 2026
Expiration Date: January 30, 2027
Expiration Date:
Activity Overview
An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. The intensive 3-day interactive program provides a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.
This educational activity is an archive of the live program held from November 6 to 8, 2025.
Target Audience
This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who desire to increase their knowledge and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate molecular and genomic testing into the treatment planning process to select the optimal therapeutic strategies for individual patients with breast cancer
- Explore current and emerging imaging modalities, and their appropriate uses, for diagnosing, staging, and monitoring patients with breast cancer
- Discuss best practices and emerging approaches in the locoregional management of breast cancer, including surgical and radiation modalities, and the role of multidisciplinary treatment planning, to optimize patient outcomes and prevent or minimize adverse events
- Assess foundational evidence from clinical trials establishing current standards in systemic therapies for breast cancer, and emerging results from trials evaluating novel strategies that may shape future treatment options